Balance exercises for people living with glaucoma
Tests a balance training program in adults with glaucoma, compared with routine care.
Key facts
- Who runs it
- Kanuni Sultan Suleyman Training and Research Hospital
- Where
- Küçükçekmece, TürkiyeSee the site
- Trial code
- Registry title
- Effects of Balance Training in Individuals With Glaucoma
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 5 Aug 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Balance Training Program
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with primary open-angle glaucoma and stable glaucoma treatment who can walk on their own. It tests an eight-week balance training program.
- Age
- Over 18 years
- Sex
- All sexes
- Disease stage
- Primary open-angle glaucoma
- Earlier treatment
- Glaucoma treatment must have been stable for the last 3 months: no change in anti-glaucoma medication, no new surgery or laser treatment, and no finding at eye check-ups that needed a change. No regular balance exercise or vestibular rehabilitation program in the last 6 months.
Main reasons for not taking part
- Eye surgery in the last 3 months
- Another eye disease that could greatly affect balance, such as advanced cataract, age-related macular degeneration or proliferative diabetic retinopathy
- Stroke, Parkinson's disease, multiple sclerosis or another neurological disorder
- Vestibular (inner ear balance) disorder, or a leg or foot condition that greatly affects balance and walking, or leg surgery in the last 6 months
- Cognitive or psychiatric disorder that would make it hard to follow the study, or severe heart or lung disease that prevents exercise
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Being over 18 years of age
- Diagnosis of primary open-angle glaucoma
- Glaucoma treatment being stable for the last 3 months (Stable treatment is defined as: no changes to anti-glaucoma medication, no new surgical or laser treatments, and no clinical findings during routine eye examinations necessitating a change in treatment within the last 3 months.)
- Ability to walk independently
- Ability to understand and follow simple verbal commands
- General health status suitable for participating in balance exercises
- Willingness to participate in the study and provide written informed consent
Who cannot take part
- Having undergone eye surgery within the last 3 months
- Presence of stroke, Parkinson's disease, multiple sclerosis, or other neurological disorders
- History of vestibular system disorder
- Lower extremity orthopedic condition significantly affecting balance and gait, or lower extremity surgery within the last 6 months
- Presence of cognitive or psychiatric disorders that would hinder adherence to the study
- Presence of severe cardiopulmonary disease that would prevent participation in exercise
- Presence of an eye disease other than glaucoma that could significantly affect balance (e.g., advanced cataract, age-related macular degeneration, proliferative diabetic retinopathy)
- Participation in a regular balance exercise or vestibular rehabilitation program within the last 6 months
Where in Türkiye
- Kanuni Sultan Suleyman Education and Research HospitalKüçükçekmece, TürkiyeContact: Hatice Zehra FERHATLARTaking people
About the trial
What the trial wants to find out
Glaucoma is a chronic progressive eye disease characterized by visual field loss, which may adversely affect postural control, functional mobility, and increase the risk and fear of falling. This randomized controlled trial aims to investigate the effects of balance training on balance performance, fall risk, and fear of falling in individuals with glaucoma. Participants will be randomly assigned to either a balance training group or a control group. The intervention group will participate in a structured balance training program for eight weeks, while the control group will continue their routine medical care. Balance performance, functional mobility/fall risk, and fear of falling will be assessed using the Berg Balance Scale, Timed Up and Go Test, and Falls Efficacy Scale-Internatio
The 2 groups in the trial
- Balance Training GroupTreatment being tested
Participants in this group will receive a structured balance training program for 8 weeks in addition to their routine glaucoma care. The balance training program will include static and dynamic balance exercises, gait-related balance activities, and progressive postural control exercises.
Treatment: Balance Training Program
- Control GroupNo study treatment, for comparison
Participants in this group will continue their routine glaucoma care and will not receive the balance training program during the 8-week study period. Outcome assessments will be performed at baseline and at the end of 8 weeks using the same assessment procedures as the balance training group.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Balance Training on Balance Performance, Fall Risk, and Fear of Falling in Individuals With Glaucoma: A Randomized Controlled Trial
- Plain-language title
- Balance exercises for people living with glaucomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 2 November 2026